Latest Cashflow News

Reckon Limited delivered a robust half-year performance in HY25, driven by strong cloud revenue growth and a key acquisition that expanded its SME client base. The company also declared a fully franked dividend, underscoring confidence in its ongoing strategy.

Reckon Limited has reported a robust first half of 2025, marked by significant revenue and profit growth fueled by organic expansion and the acquisition of Cashflow Manager. The company’s cloud-based Reckon One product and US-focused Legal Group continue to drive momentum.

Javelin Minerals has announced a significant 15% increase in recoverable gold ounces at its Eureka Gold Project, alongside a 32% rise in grade, setting the stage for enhanced production and cashflow in 2026.

Medallion Metals has executed a binding agreement to acquire the Forrestania Nickel Operation from IGO Limited, setting the stage for a low-capital pathway to gold and copper production at its Ravensthorpe project. The transaction targets completion and a final investment decision by late 2025.

8common Limited has closed FY25 with a positive operational cash flow and EBITDA, driven by record SaaS revenue and significant margin improvements following major infrastructure upgrades.

ADX Energy reported a 23% rise in production to 303 BOEPD for Q2 2025, offsetting a 10% drop in Brent oil prices, while advancing key drilling plans and awaiting new permit awards.

High-Tech Metals has completed a transformative acquisition of the Mt Fisher and Mt Eureka gold projects, expanding its footprint in Western Australia's Northern Goldfields and setting the stage for aggressive exploration and early production.

Skin Elements Limited advances its proprietary SE Formula biotechnology with ECO-Nurture poised for commercial rollout in 2026, alongside progress in disinfectant and sunscreen product lines.

Medical Developments International (MVP) reports positive operating cash flow in H2 FY25, driven by strong Penthrox sales and strategic distribution shifts in Europe. The company eyes further growth amid regulatory progress and efficiency gains.

Resonance Health reports a solid quarter with key clinical trial milestones, expansion of trial sites, and multi-year Software-as-a-Medical Device contracts, underpinning a positive cashflow outlook.

Pointerra Limited reported strong FY25 Q4 results marked by new enterprise customers, a major US defense subcontract, and significant cashflow improvements. The company’s AI-enhanced digital twin platform is gaining traction across multiple sectors, setting the stage for growth in FY26.

Micro-X has landed a significant supply agreement with a top US healthcare provider for its Rover Plus mobile X-ray units, while progressing clinical trials and development milestones for its innovative CT imaging products.